You are hereby cordially invited to attend the 2017 Annual Meeting of Stockholders of Northwest Biotherapeutics, Inc., (the “Company”) which will be held on January 21, 2018 at 1:30 p.m. (local time) at the offices of Gibson, Dunn & Crutcher LLP, 1050 Connecticut Avenue NW, Washington, DC 20036, and any adjournments or postponements of the Annual Meeting. We are holding the Annual Meeting for the following purposes: 1. To elect one member to our Board of Directors to serve as Class II director for a term of three years; 2. To hold an advisory vote on executive compensation; 3. To ratify the appointment of Marcum LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017; and 4. To act upon such other matters as may properly come before the meeting or any adjournment thereof.
I think some shareholders whom are looking to attend, are planning to be there an hour prior to the meeting start, so that they might be able to ask some questions.